oxybutynin has been researched along with Dermatitis, Contact, Photoallergic in 3 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketoprofen tape and gel were used as test formulations." | 2.79 | Elimination of ketoprofen from the stratum corneum after topical administration with ketoprofen formulations in human subjects. ( Ebihara, T; Higo, N; Maekawa, K; Takeshi, M; Yamamoto, K, 2014) |
| "Ketoprofen (KP) is a widely used transdermal non-steroidal anti-inflammatory drug." | 1.37 | Titanium dioxide inclusion in backing reduce the photoallergenicity of ketoprofen transdermal patch. ( Ah, YC; Bae, IH; Bae, JH; Choi, YG; Ki, HM; Lee, JH; Lee, KC; Lim, KM; Park, YH, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeshi, M | 1 |
| Ebihara, T | 1 |
| Maekawa, K | 1 |
| Yamamoto, K | 1 |
| Higo, N | 1 |
| Choi, YG | 1 |
| Lee, JH | 1 |
| Bae, IH | 1 |
| Ah, YC | 1 |
| Ki, HM | 1 |
| Bae, JH | 1 |
| Park, YH | 1 |
| Lee, KC | 1 |
| Lim, KM | 1 |
| Hogan, DJ | 1 |
| Saenz, AB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Photoallergic Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers[NCT01119651] | Phase 1 | 59 participants (Actual) | Interventional | 2010-06-14 | Completed | ||
| A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled Study To Evaluate The Phototoxic Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers[NCT01115322] | Phase 1 | 38 participants (Actual) | Interventional | 2010-04-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for oxybutynin and Dermatitis, Contact, Photoallergic
| Article | Year |
|---|---|
Elimination of ketoprofen from the stratum corneum after topical administration with ketoprofen formulations in human subjects.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical | 2014 |
Phototoxic and photoallergic potential of tazarotene foam 0.1% in 2 phase 1 patch studies.
Topics: Adolescent; Adult; Aged; Dermatitis, Photoallergic; Dermatitis, Phototoxic; Dosage Forms; Female; Hu | 2012 |
Phototoxic and photoallergic potential of tazarotene foam 0.1% in 2 phase 1 patch studies.
Topics: Adolescent; Adult; Aged; Dermatitis, Photoallergic; Dermatitis, Phototoxic; Dosage Forms; Female; Hu | 2012 |
Phototoxic and photoallergic potential of tazarotene foam 0.1% in 2 phase 1 patch studies.
Topics: Adolescent; Adult; Aged; Dermatitis, Photoallergic; Dermatitis, Phototoxic; Dosage Forms; Female; Hu | 2012 |
Phototoxic and photoallergic potential of tazarotene foam 0.1% in 2 phase 1 patch studies.
Topics: Adolescent; Adult; Aged; Dermatitis, Photoallergic; Dermatitis, Phototoxic; Dosage Forms; Female; Hu | 2012 |
1 other study available for oxybutynin and Dermatitis, Contact, Photoallergic
| Article | Year |
|---|---|
Titanium dioxide inclusion in backing reduce the photoallergenicity of ketoprofen transdermal patch.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutic | 2011 |